AAAAAA
Results: 1-25/33
Authors:
Lower, EE
Hawkins, HH
Baughman, RP
Citation: Ee. Lower et al., Breast disease in sarcoidosis, SARCO VASC, 18(3), 2001, pp. 301-306
Authors:
Baughman, RP
Lower, EE
Citation: Rp. Baughman et Ee. Lower, Infliximab for refractory sarcoidosis (vol 18, pg 70, 2001), SARCO VASC, 18(3), 2001, pp. 310-310
Authors:
Baughman, RP
Ohmichi, M
Lower, EE
Citation: Rp. Baughman et al., Combination therapy for sarcoidosis, SARCO VASC, 18(2), 2001, pp. 133-137
Authors:
Baughman, RP
Lower, EE
Citation: Rp. Baughman et Ee. Lower, Infliximab for refractory sarcoidosis, SARCO VASC, 18(1), 2001, pp. 70-74
Authors:
Chang, B
Steimel, J
Moller, DR
Baughman, RP
Judson, MA
Yeager, H
Teirstein, AS
Rossman, MD
Rand, CS
Citation: B. Chang et al., Depression in sarcoidosis, AM J R CRIT, 163(2), 2001, pp. 329-334
Authors:
Baughman, RP
Drent, M
Citation: Rp. Baughman et M. Drent, Role of bronchoalveolar lavage in interstitial lung disease, CLIN CHEST, 22(2), 2001, pp. 331
Authors:
Amin, RS
Wert, SE
Baughman, RP
Tomashefski, JF
Nogee, LM
Brody, AS
Hull, WM
Whitsett, JA
Citation: Rs. Amin et al., Surfactant protein deficiency in familial interstitial lung disease, J PEDIAT, 139(1), 2001, pp. 85-92
Authors:
Baughman, RP
Citation: Rp. Baughman, Agents other than glucocorticoids in sarcoidosis, SARCO VASC, 17(2), 2000, pp. 184-185
Authors:
Baughman, RP
Winget, DB
Lower, E
Citation: Rp. Baughman et al., Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial, SARCO VASC, 17(1), 2000, pp. 60-66
Authors:
Baddour, LM
Khardori, N
Nicolau, DP
Baughman, RP
Barie, PS
Citation: Lm. Baddour et al., Synercid: A new antibiotic for gram-positive infections, FORMULARY, 35, 2000, pp. S16
Authors:
Beard, CB
Carter, JL
Keely, SP
Huang, L
Pieniazek, NJ
Moura, INS
Roberts, JM
Hightower, AW
Bens, MS
Freeman, AR
Lee, S
Stringer, JR
Duchin, JS
del Rio, C
Rimland, D
Baughman, RP
Levy, DA
Dietz, VJ
Simon, P
Navin, TR
Citation: Cb. Beard et al., Genetic variation in Pneumocystis carinii isolates from different geographic regions: Implications for transmission, EM INFECT D, 6(3), 2000, pp. 265-272
Authors:
Dohn, MN
White, ML
Vigdorth, EM
Buncher, CR
Hertzberg, VS
Baughman, RP
Smulian, AG
Walzer, PD
Citation: Mn. Dohn et al., Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection, AM J R CRIT, 162(5), 2000, pp. 1617-1621
Authors:
Kaneshiro, ES
Amit, Z
Chandra, J
Baughman, RP
Contini, C
Lundgren, B
Citation: Es. Kaneshiro et al., Sterols of Pneumocystis carinii hominis organisms isolated from human lungs (vol 6, pg 970, 1999), CL DIAG LAB, 7(1), 2000, pp. 129-129
Authors:
Baughman, RP
Pina, E
Citation: Rp. Baughman et E. Pina, Infections in acute exacerbation of chronic bronchitis: What are they and how do we know?, SEM RESP CR, 21(2), 2000, pp. 87-96
Authors:
Baughman, RP
Spencer, RE
Kleykamp, BO
Rashkin, MC
Douthit, MM
Citation: Rp. Baughman et al., Ventilator associated pneumonia: quality of nonbronchoscopic bronchoalveolar ravage sample affects diagnostic yield, EUR RESP J, 16(6), 2000, pp. 1152-1157
Authors:
Baughman, RP
Citation: Rp. Baughman, Protected-specimen brush technique in the diagnosis of ventilator-associated pneumonia, CHEST, 117(4), 2000, pp. 203S-206S
Authors:
Baughman, RP
Iannuzzi, MC
Citation: Rp. Baughman et Mc. Iannuzzi, Diagnosis of sarcoidosis - When is a peek good enough?, CHEST, 117(4), 2000, pp. 931-932
Authors:
Rybicki, BA
Maliarik, MJ
Bock, CH
Elston, RC
Baughman, RP
Kimani, AP
Sheffer, RG
Chen, KM
Major, M
Popovich, J
Iannuzzi, MC
Citation: Ba. Rybicki et al., The Blau syndrome gene is not a major risk factor for sarcoidosis, SARCO VASC, 16(2), 1999, pp. 203-208
Authors:
Baughman, RP
Citation: Rp. Baughman, New treatments for sarcoidosis, SARCO VASC, 16(2), 1999, pp. 233-233
Authors:
Baughman, RP
Lower, EE
Miller, MA
Bejarano, PA
Heffelfinger, SC
Citation: Rp. Baughman et al., Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis, SARCO VASC, 16(1), 1999, pp. 57-61
Authors:
Judson, MA
Baughman, RP
Teirstein, AS
Terrin, ML
Yeager, H
Citation: Ma. Judson et al., Defining organ involvement in sarcoidosis: the ACCESS proposed instrument, SARCO VASC, 16(1), 1999, pp. 75-86
Authors:
Kaneshiro, ES
Amit, Z
Chandra, J
Baughman, RP
Contini, C
Lundgren, B
Citation: Es. Kaneshiro et al., Sterols of Pneumocystis carinii hominis organisms isolated from human lungs, CL DIAG LAB, 6(6), 1999, pp. 970-976
Authors:
Chandra, J
Amit, Z
Baughman, RP
Kleykamp, B
Kaneshiro, ES
Citation: J. Chandra et al., Pneumocystis infection is correlated with a reduction of the total sterol content of human bronchoalveolar lavage fluid, J EUKAR MIC, 46(5), 1999, pp. 146S-148S
Authors:
Baughman, RP
Lower, EE
Citation: Rp. Baughman et Ee. Lower, New treatment for sarcoidosis: where's the proof?, EUR RESP J, 14(5), 1999, pp. 1000-1001
Authors:
Haslam, PL
Baughman, RP
Citation: Pl. Haslam et Rp. Baughman, Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL, EUR RESP J, 14(2), 1999, pp. 245-248